AVD-104

DRUG2 trials

Sponsors

Aviceda Therapeutics, Inc.

Conditions

Diabetic Macular EdemaDiabetic RetinopathyGeographic Atrophy of the MaculaMacular Degeneration

Phase 2

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

CompletedNCT05839041

Aviceda Therapeutics, Inc.Geographic Atrophy of the Macula, Macular Degeneration

Start: 2023-05-02End: 2026-02-18Updated: 2026-09-16

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

TerminatedNCT06181227

Aviceda Therapeutics, Inc.Diabetic Macular Edema, Diabetic Retinopathy

Start: 2023-11-30End: 2024-04-05Updated: 2025-07-14